ACS Systems Improving Delivery of Healthcare in Malta

iSOFTAffiliated Computer Services, Inc. announced that it has successfully completed Phase I of the Government of Malta's Integrated Health Information System (IHIS), program to attain the highest quality patient care for the citizens of Malta.

Along with iSOFT, a key technology partner, ACS has installed state-of-the-art IT infrastructure that connects laboratory, radiology, and image archiving communication systems and integrates them with iSOFT's Patient Administration System and Clinical Order Communication and Results Reporting System. The systems have already helped improve the delivery and management of healthcare service and records in Malta's new 850-bed Mater Dei Hospital, the nation's largest healthcare facility. ACS will also provide ongoing operations, maintenance, and integration services and support through an on-site command center.

"The rapid implementation of this system was designed to provide quick benefits to the citizens of Malta," said Charles Bracken, managing director of ACS Healthcare Solutions. "Not only were we required to install new digital technology, but laboratory and radiology services had to be completely updated in the process, and all of this needed to happen while Mater Dei Hospital was moving to a new campus."

"By developing and deploying important IT partnerships, we were able to meet our aggressive deadlines. We transferred our healthcare knowledge to the Government of Malta in record time. Now we look forward to leveraging our global healthcare experience and expertise to help Mater Dei Hospital provide world-class care to those who need it most," he said.

Mater Dei's 150 laboratory scientists conduct 4.5 million tests each year for healthcare professionals throughout Malta. Replacing largely manual processes, iSOFT's i.Laboratory systems will speed the turnaround of test results, increase the accuracy of test data and patient information, enhance the legibility of critical reports, and provide better access to patient demographics and specimen records, all improving the quality and efficiency of healthcare delivery.

"Meticulous planning and great team work with ACS enabled us to meet an urgent customer need," said Paul Richards, managing director of iSOFT in the United Kingdom and Ireland. "This implementation took less than five months to complete, which is a considerable achievement for a project of this scale and complexity."

i.Laboratory also allows tests, samples, and results to be tracked across all of the hospital's laboratories, including chemistry, haematology, immunology, microbiology, virology, toxicology, pathology, and cytology. Ultimately every ward within Mater Dei will be able to order tests and view the results online.

Related news articles:

About iSOFT
iSOFT is an IBA Health Group company.

IBA Health Group Limited is the largest specialist information technology company listed on the Australian Securities Exchange. Today, over 13,000 provider organisations in 35 countries across five continents use IBA's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of our market, and anticipation of evolving requirements. Its business is driven by the collective talent, experience, and commitment of over 3,500 healthcare IT experts around the globe. A global network of IBA subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result IBA offers its customers comprehensive knowledge of local market requirements, in terms of culture, language, working practice, healthcare regulation, and organisational structure.

About ACS
ACS, a global FORTUNE 500 company with 62,000 people supporting client operations reaching more than 100 countries, provides business process outsourcing and information technology solutions to world-class commercial and government clients. The company's Class A common stock trades on the New York Stock Exchange under the symbol "ACS". Learn more about ACS at www.acs-inc.com.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...